GlassScriptPhysician profile
Jacquelyn Mcginness
NPI 1699856393
$1,915.69
in general payments reported to CMS, 2019-2025
18 companies · $375 in 2025
The $375 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $253 · 2022: $662 · 2023: $294 · 2024: $331 · 2025: $375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $885 · Education: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $885.38 |
| Education | $115.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $312.18 | 2022-2025 | |
| Leo Pharma INC. | $258.17 | 2022-2024 | Adbry |
| Novartis Pharmaceuticals Corporation | $248.47 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $178.85 | 2021-2023 | Dupixent |
| Genzyme Corporation | $149.47 | 2022-2025 | |
| Pfizer INC. | $128.63 | 2021-2025 | |
| Janssen Biotech, INC. | $116.74 | 2022-2023 | Tremfya |
| Galderma Laboratories, L.P. | $112.78 | 2021-2025 | Nemluvio |
| Ucb, INC. | $76.79 | 2021-2024 | Bimzelx |
| Incyte Corporation | $65.72 | 2024-2025 | Opzelura |
| Lilly USA, LLC | $60.27 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $44.67 | 2022-2025 | Sotyktu |
| Almirall LLC | $43.16 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $31.95 | 2021 | |
| Journey Medical Corporation | $25.01 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $23.81 | 2021 | |
| Arcutis Biotherapeutics, INC. | $21.86 | 2025 | Zoryve |
| Sun Pharmaceutical Industries INC. | $17.16 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacquelyn Mcginness listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.